NYSE$CE
Celanese Corp · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Celanese reported a significant net loss in Q4 2024, primarily due to non-cash asset impairment charges, despite efforts to reduce costs and align production with demand.
Celanese Corporation reported a net loss of $1.911 billion for the fourth quarter of 2024, a significant decline from a net income of $120 million in the previous quarter and $701 million in the same period last year. This was largely driven by a $2.0 billion impact from Certain Items, predominantly non-cash asset impairment charges. Net sales decreased by 10% sequentially to $2.4 billion, impacted by volume and price declines, and challenging demand in key end-markets.
- Net sales for Q4 2024 were $2.370 billion, a 10% sequential decrease.
- The company reported a net loss of $1.911 billion for Q4 2024, compared to net earnings of $120 million in Q3 2024.
- Diluted EPS for Q4 2024 was -$17.50, a substantial drop from $1.06 in Q3 2024.
- Adjusted EBIT for Q4 2024 was $333 million, down from $457 million in Q3 2024.
Headline financials
Revenue & EPS history
Celanese · Revenue · Quarterly
$2.37B
Revenue by segment
Celanese · $2.75B total across 2 segments · Q3 2023
- Engineered Materials$1.53B+64.5%55.6%
- Acetyl Chain$1.22B-4.2%44.4%
Forward guidance
Celanese anticipates continued demand and pricing challenges in Q1 2025, with additional headwinds from seasonality and a planned outage. However, they expect meaningful sequential improvement in Q2 2025.
Tailwinds
- Anticipates meaningful sequential improvement in the second quarter.
- Expects second quarter earnings per share to be approximately $1.00 higher than the first quarter.
- Company is focused on intensifying cost reduction.
- Driving growth through AC optionality and EM pipeline models.
- Increasing cash flow to deleverage the balance sheet.
Headwinds
- Expects sequential demand and pricing challenges to be largely unchanged in the first quarter.
- Continued weakness in core end-markets like automotive, construction, paints, coatings, and industrial.
- Additional headwinds in Q1 from seasonality in acetate tow and medical implants businesses.
- Planned outage at the Bishop, Texas facility in Q1.
- Delay until Q2 for dividend income from the acetate joint venture in China due to law change.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+0.3%
Avg return
Earnings day
-1.4%
Avg return
5 days after
+1.3%
Avg return
30 days after
56%
41 / 73 earnings
Positive
+16.4%
Q1 2015
Best reaction
-27.1%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.6% | -13.9% | -26.1% | |
| Q4 2025 | -1.6% | -6.1% | +2.2% | |
| Q3 2025 | +14.5% | +8.3% | +12.5% | |
| Q2 2025 | -13.1% | -10.4% | -1.2% | |
| Q1 2025 | +10.0% | +14.4% | +21.8% | |
| Q4 2024 | -21.5% | -24.3% | -18.3% | |
| Q3 2024 | -27.1% | -32.1% | -43.2% | |
| Q2 2024 | -6.8% | -10.0% | -7.5% | |
| Q1 2024 | -0.8% | -1.5% | -10.0% | |
| Q4 2023 | -0.5% | -1.1% | +11.4% | |
| Q3 2023 | -3.6% | -2.0% | +16.5% | |
| Q2 2023 | +1.1% | +1.7% | +2.4% | |
| Q1 2023 | -2.9% | -4.9% | +9.1% | |
| Q4 2022 | +3.1% | +1.8% | -11.1% | |
| Q3 2022 | -2.2% | -0.2% | +16.1% | |
| Q2 2022 | -0.5% | -5.7% | -3.6% | |
| Q1 2022 | +4.9% | +7.3% | +13.7% | |
| Q4 2021 | -4.0% | -1.3% | -11.5% | |
| Q3 2021 | +1.2% | +3.0% | -0.5% | |
| Q2 2021 | +0.9% | +1.7% | +1.5% | |
| Q1 2021 | -0.9% | -1.3% | +3.5% | |
| Q4 2020 | +2.3% | +4.7% | +16.4% | |
| Q3 2020 | -3.9% | -5.6% | +14.4% | |
| Q2 2020 | +2.1% | +2.1% | +8.2% | |
| Q1 2020 | +4.0% | +0.7% | +19.4% | |
| Q4 2019 | -7.5% | -4.1% | -16.3% | |
| Q3 2019 | -1.9% | +1.6% | +2.1% | |
| Q2 2019 | +3.0% | +3.8% | +5.7% | |
| Q1 2019 | +6.6% | +3.2% | -4.8% | |
| Q4 2018 | -1.0% | +1.5% | +6.3% | |
| Q3 2018 | -0.1% | +0.3% | +2.7% | |
| Q2 2018 | +2.1% | +2.9% | +4.3% | |
| Q1 2018 | +6.0% | +7.2% | +6.7% | |
| Q4 2017 | +1.1% | -0.3% | -5.6% | |
| Q3 2017 | -2.9% | -1.6% | -3.9% | |
| Q2 2017 | -1.4% | -3.2% | +0.4% | |
| Q1 2017 | -0.1% | -0.9% | -5.9% | |
| Q4 2016 | +3.9% | +4.3% | +6.6% | |
| Q3 2016 | +9.5% | +11.5% | +24.2% | |
| Q2 2016 | -6.4% | -9.7% | -6.1% | |
| Q1 2016 | +0.6% | — | — | |
| Q4 2015 | +3.2% | — | — | |
| Q3 2015 | +2.3% | — | — | |
| Q2 2015 | -4.7% | — | — | |
| Q1 2015 | +16.4% | — | — | |
| Q4 2014 | -7.6% | — | — | |
| Q3 2014 | +8.2% | — | — | |
| Q2 2014 | -2.3% | — | — | |
| Q1 2014 | +2.5% | — | — | |
| Q4 2013 | -4.3% | — | — | |
| Q3 2013 | +5.4% | — | — | |
| Q2 2013 | +0.8% | — | — | |
| Q1 2013 | +11.2% | — | — | |
| Q4 2012 | +2.4% | — | — | |
| Q3 2012 | +2.5% | — | — | |
| Q2 2012 | +4.5% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q4 2011 | -1.0% | — | — | |
| Q3 2011 | +9.9% | — | — | |
| Q2 2011 | -0.9% | — | — | |
| Q1 2011 | +0.2% | — | — | |
| Q4 2010 | +0.7% | — | — | |
| Q3 2010 | +1.6% | — | — | |
| Q2 2010 | -1.2% | — | — | |
| Q1 2009 | -5.7% | — | — | |
| Q1 2010 | +0.1% | — | — | |
| Q4 2007 | +0.0% | — | — | |
| Q4 2009 | +0.0% | — | — | |
| Q3 2008 | +3.6% | — | — | |
| Q3 2009 | +3.6% | — | — | |
| Q4 2008 | +0.5% | — | — | |
| Q2 2009 | +0.5% | — | — | |
| Q2 2008 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro